Cargando…

Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study

Detalles Bibliográficos
Autores principales: Huang, Cheng, Xu, Bin, Zhu, Xiao‐Dong, Shen, Ying‐Hao, Li, Mei‐Ling, Zhu, Jin‐Jin, Zhou, Jian, Fan, Jia, Sun, Hui‐Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648393/
https://www.ncbi.nlm.nih.gov/pubmed/35994567
http://dx.doi.org/10.1002/cac2.12350
_version_ 1784827577933758464
author Huang, Cheng
Xu, Bin
Zhu, Xiao‐Dong
Shen, Ying‐Hao
Li, Mei‐Ling
Zhu, Jin‐Jin
Zhou, Jian
Fan, Jia
Sun, Hui‐Chuan
author_facet Huang, Cheng
Xu, Bin
Zhu, Xiao‐Dong
Shen, Ying‐Hao
Li, Mei‐Ling
Zhu, Jin‐Jin
Zhou, Jian
Fan, Jia
Sun, Hui‐Chuan
author_sort Huang, Cheng
collection PubMed
description
format Online
Article
Text
id pubmed-9648393
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96483932022-11-14 Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study Huang, Cheng Xu, Bin Zhu, Xiao‐Dong Shen, Ying‐Hao Li, Mei‐Ling Zhu, Jin‐Jin Zhou, Jian Fan, Jia Sun, Hui‐Chuan Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-08-22 /pmc/articles/PMC9648393/ /pubmed/35994567 http://dx.doi.org/10.1002/cac2.12350 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Huang, Cheng
Xu, Bin
Zhu, Xiao‐Dong
Shen, Ying‐Hao
Li, Mei‐Ling
Zhu, Jin‐Jin
Zhou, Jian
Fan, Jia
Sun, Hui‐Chuan
Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
title Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
title_full Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
title_fullStr Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
title_full_unstemmed Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
title_short Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
title_sort peripheral naïve cd8(+) t cells as a predictive biomarker of response to lenvatinib plus an anti‐pd‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648393/
https://www.ncbi.nlm.nih.gov/pubmed/35994567
http://dx.doi.org/10.1002/cac2.12350
work_keys_str_mv AT huangcheng peripheralnaivecd8tcellsasapredictivebiomarkerofresponsetolenvatinibplusanantipd1antibodyinadvancedhepatocellularcarcinomaabiomarkerstudy
AT xubin peripheralnaivecd8tcellsasapredictivebiomarkerofresponsetolenvatinibplusanantipd1antibodyinadvancedhepatocellularcarcinomaabiomarkerstudy
AT zhuxiaodong peripheralnaivecd8tcellsasapredictivebiomarkerofresponsetolenvatinibplusanantipd1antibodyinadvancedhepatocellularcarcinomaabiomarkerstudy
AT shenyinghao peripheralnaivecd8tcellsasapredictivebiomarkerofresponsetolenvatinibplusanantipd1antibodyinadvancedhepatocellularcarcinomaabiomarkerstudy
AT limeiling peripheralnaivecd8tcellsasapredictivebiomarkerofresponsetolenvatinibplusanantipd1antibodyinadvancedhepatocellularcarcinomaabiomarkerstudy
AT zhujinjin peripheralnaivecd8tcellsasapredictivebiomarkerofresponsetolenvatinibplusanantipd1antibodyinadvancedhepatocellularcarcinomaabiomarkerstudy
AT zhoujian peripheralnaivecd8tcellsasapredictivebiomarkerofresponsetolenvatinibplusanantipd1antibodyinadvancedhepatocellularcarcinomaabiomarkerstudy
AT fanjia peripheralnaivecd8tcellsasapredictivebiomarkerofresponsetolenvatinibplusanantipd1antibodyinadvancedhepatocellularcarcinomaabiomarkerstudy
AT sunhuichuan peripheralnaivecd8tcellsasapredictivebiomarkerofresponsetolenvatinibplusanantipd1antibodyinadvancedhepatocellularcarcinomaabiomarkerstudy